Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Julphar
Cipla
Fish and Richardson
Merck
US Army
Mallinckrodt
Argus Health
McKesson

Generated: June 24, 2018

DrugPatentWatch Database Preview

HEXAMINOLEVULINATE HYDROCHLORIDE - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for hexaminolevulinate hydrochloride and what is the scope of hexaminolevulinate hydrochloride freedom to operate?

Hexaminolevulinate hydrochloride
is the generic ingredient in one branded drug marketed by Photocure Asa and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Hexaminolevulinate hydrochloride has ten patent family members in eight countries.

One supplier is listed for this compound.
Synonyms for HEXAMINOLEVULINATE HYDROCHLORIDE
140898-91-5
5-amino-4-oxopentanoic acid hexyl ester hydrochloride
5-Aminolevulinic acid hexyl ester hydrochloride
5-Aminolevulinic acid hexylester hydrochloride
6842AA
898A915
A-6140
AC1O5FJ4
AK-59194
AKOS016002051
ala hexyl ester hydrochloride
AM84373
aminolevulinc acid hexyl ester
aminolevulinic acid hexyl ester hydrochloride
AN-31604
ANW-58882
AX8102340
C11H22ClNO3
CHEMBL1201785
CS-5206
CTK8B7894
Cysview
Cysview (TN)
Cysview Kit
D04436
D0AY9Q
D4F329SL1O
DB-063352
delta-aminolevulinic acid hexyl ester hydrochloride
DTXSID80161486
FT-0767765
Hexaminolevulinate (hydrochloride)
hexaminolevulinate HCl
Hexaminolevulinate hydrochloride (USAN)
Hexaminolevulinate Hydrochloride [USAN]
Hexaminolevulinate hydrochloride, >=98% (HPLC)
HexvisR
Hexvix
Hexvix (TN)
hexyl 5-amino-4-oxo-pentanoate hydrochloride
Hexyl 5-amino-4-oxopentanoate hydrochloride
hexyl aminolevulinate
HY-16045
LZYXPFZBAZTOCH-UHFFFAOYSA-N
MFCD03695491
MolPort-016-582-410
n-hexyl 5-aminolevulinate hydrochloride
OR1924
P 1206
P-1026
P-1206
Pentanoic acid, 5-amino-4-oxo-, hexyl ester, hydrochloride
SCHEMBL937621
TC-147627
UNII-D4F329SL1O
ZX-AT022126

US Patents and Regulatory Information for HEXAMINOLEVULINATE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for HEXAMINOLEVULINATE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 ➤ Try a Free Trial ➤ Try a Free Trial
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 ➤ Try a Free Trial ➤ Try a Free Trial
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Johnson and Johnson
Deloitte
Boehringer Ingelheim
UBS
Federal Trade Commission
Julphar
Cipla
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.